Patents by Inventor Esther Bataller Leiva

Esther Bataller Leiva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10603342
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: March 31, 2020
    Assignee: Compagnie Gervais Danone
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • Patent number: 9802990
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus. These peptides, extracts containing them and food products containing them are useful for the treatment and/or prevention of obesity and oxidative stress.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: October 31, 2017
    Assignee: DANONE, S.A.
    Inventors: Agusti Montserrat Carreras, Cristina Alvarez Fernandez, Montserrat Andreu Corominas, Daniel Ramón Vidal, Esther Bataller Leiva, Patricia Martorell Guerola, Salvador Genovés Martínez
  • Publication number: 20170145379
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Application
    Filed: October 6, 2016
    Publication date: May 25, 2017
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • Publication number: 20160002303
    Abstract: The present invention concerns certain peptides obtainable by hydrolysis from soy glycinin by the action of supernatant cultures of strains belonging to the genera Lactobacillus or Streptococcus.
    Type: Application
    Filed: February 19, 2013
    Publication date: January 7, 2016
    Applicant: DANONE, S.A.
    Inventors: Agusti MONTSERRAT CARRERAS, Cristina ALVAREZ FERNÁNDEZ, Montserrat ANDREU COROMINAS, Daniel RAMÓN VIDAL, Esther BATALLER LEIVA, Patricia MARTORELL GUEROLA, Salvador GENOVÉS MARTÍNEZ
  • Patent number: 8946383
    Abstract: The present invention relates to obtaining bioactive peptides from plant raw materials, specifically cocoa extracts, by means of enzyme treatment. Said biopeptides have angiotensin converting enzyme (ACE) and prolyl endopeptidase enzyme (PEP) inhibitory activity in vitro and/or antioxidant activity in vivo, being able to be used in the food, dietetic and pharmaceutical industry.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: February 3, 2015
    Assignee: Naturex
    Inventors: Begoña Muguerza Marquínez, Honorato Monzo Oltra, Natalia Alepuz Rico, Esther Bataller Leiva, Salvador Genoves Martínez, Maria Enrique López, Patricia Guerola Guerola, Daniel Ramon Vidal
  • Publication number: 20130121976
    Abstract: The present invention discloses strains of Lactobacillus and Streptococcus which have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.
    Type: Application
    Filed: March 12, 2010
    Publication date: May 16, 2013
    Inventors: Agusti Montserrat Carreras, Montserrat Andreu Corominas, Daniel Ramon Vidal, Salvador Genoves Martinez, Esther Bataller Leiva
  • Publication number: 20130035291
    Abstract: The present invention relates to the production of bioactive products from raw plant matter, namely cocoa extracts. The said products have one or more biopeptides with prolyl endopeptidase (PEP) enzyme inhibitory activity in vitro and/or antioxidant and/or antineurodegenerative capacity in vivo and can be used in dietetics and in the food and pharmaceutical industries.
    Type: Application
    Filed: December 23, 2009
    Publication date: February 7, 2013
    Applicants: NATRACEUTICAL INDUSTRIAL S.L.U., BIOPOLIS, S.L.
    Inventors: Esther Bataller Leiva, Salvador Genoves Martinez, Patricia Martorell Guerola, Daniel Ramon Vidal, Aida Ibañnez Lopez, Silvia Llopis Pla, Nuria Gonzalez Martinez, Honorato Monzo Oltra, Begoña Muguerza Marquinez
  • Publication number: 20110213122
    Abstract: The present invention relates to obtaining bioactive peptides from plant raw materials, specifically cocoa extracts, by means of enzyme treatment. Said biopeptides have angiotensin converting enzyme (ACE) and prolyl endopeptidase enzyme (PEP) inhibitory activity in vitro and/or antioxidant activity in vivo, being able to be used in the food, dietetic and pharmaceutical industry.
    Type: Application
    Filed: August 1, 2008
    Publication date: September 1, 2011
    Applicants: NATRACEUTICAL, S.A., BIOPOLIS, S.L.
    Inventors: Begona Muguerza Marquinez, Honorato Monzo Oltra, Natalia Alepuz Rico, Esther Bataller Leiva, Salvador Genoves Martínez, Maria Enrique López, Patricia Martorell Guerola, Daniel Ramon Vidal
  • Publication number: 20100034954
    Abstract: The invention relates to a method for obtaining fibre-rich cocoa with low carbon hydrate and methylxanthine contents and resulting cocoa powder which is suitable for animal feed. The inventive method includes the following main steps in which: the whole cocoa beans undergo cleaning, deffating, treatment with alpha-amylase, centrifugation, extraction-washing and subsequent centrifugation, separation, drying and grinding.
    Type: Application
    Filed: July 24, 2007
    Publication date: February 11, 2010
    Applicant: NATRACEUTICAL, S.A.
    Inventors: Leila Moulay, Esther Bataller Leiva, Daniel Ramon Vidal, Salvador Genoves Martinez